1,2-dipalmitoylphosphatidylcholine and Hepatitis B

1,2-dipalmitoylphosphatidylcholine has been researched along with Hepatitis B in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Altclas, J; Antunez, E; Arndtz, N; Dupont, J; Janowicz, Z; Lepetic, A; Lombardo, M; Salgueira, C; Seigelchifer, M; Vázquez, V; von Eschen, K	1

Trials

1 trial(s) available for 1,2-dipalmitoylphosphatidylcholine and Hepatitis B

Article	Year
A controlled clinical trial comparing the safety and immunogenicity of a new adjuvanted hepatitis B vaccine with a standard hepatitis B vaccine. Vaccine, 2006, Nov-30, Volume: 24, Issue:49-50 Topics: 1,2-Dipalmitoylphosphatidylcholine; Adjuvants, Immunologic; Adolescent; Adult; Cohort Studies; Dose-Response Relationship, Immunologic; Double-Blind Method; Excipients; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Male; Suspensions	2006

Article

Year

A controlled clinical trial comparing the safety and immunogenicity of a new adjuvanted hepatitis B vaccine with a standard hepatitis B vaccine.

Vaccine, 2006, Nov-30, Volume: 24, Issue:49-50

Topics: 1,2-Dipalmitoylphosphatidylcholine; Adjuvants, Immunologic; Adolescent; Adult; Cohort Studies; Dose-Response Relationship, Immunologic; Double-Blind Method; Excipients; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Male; Suspensions

2006